Trevi Therapeutics (TRVI) Q1 2025 Earnings

Mar 18Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.13
-0.12
-0.1
-0.09

Details

Expected EPS
-0.128182
Actual EPS
-0.11
Surprise EPS
0.02
Surprise Percent
+14.18%

Description

⁨Trevi Therapeutics⁩ (⁦TRVI⁩) has reported earnings of ⁦-0.11⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts